XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED BALANCE SHEET - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 217,474 $ 15,306
Accounts receivable, net 263,480 536,817
Inventory, net 488,761 318,912
Prepaid expenses and other current assets 183,225 127,258
Total current assets 1,152,940 998,293
Restricted Cash 0 209,570
Property and equipment, net 7,130 11,064
Patents, net 160,000 250,000
Goodwill 3,474,502 3,474,502
Total assets 4,794,572 4,943,429
Current Liabilities:    
Accounts payable and accrued expenses 1,588,255 1,258,252
Debt, short-term 514,353 109,682
Derivative liabilities 67,528 5,792,572
Total current liabilities 2,170,136 7,160,506
Debt, long-term 1,570,963 0
Total Liabilities 3,741,099 7,160,506
Commitments and Contingencies (Note 7)
Stockholders' Equity    
Common Stock, $0.001 par value, 300,000,000 shares authorized, 214,622,929 and 119,402,009 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 214,623 119,402
Additional paid in capital 42,625,878 33,456,325
Accumulated deficit (41,788,458) (35,794,206)
Total Stockholders’ Equity (Deficit) 1,053,473 (2,217,077)
Total Liabilities and Stockholders’ Equity (Deficit) 4,794,572 4,943,429
Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 1,285 1,293
Series C Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 106 109
Series D Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock $ 39 $ 0